Prepacked chromatography columns are prepacked cartridges containing separation media for the purification and isolation of biomolecules. These columns offer advantages such as ease-of-use, ready-to-use format and minimized preparation time. They find wide application in pharmaceutical, biopharmaceutical and food & beverage industries for downstream and upstream processing, Quality control testing and analytical separations. The need for high purity biotherapeutic drugs and stringent regulatory guidelines regarding purity is driving the demand for prepacked chromatography columns.
The global Prepacked Chromatography Columns Market is estimated to be valued at US$ 307.6 Mn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising pharmaceutical industry in emerging economies is a major factor driving the growth of prepacked chromatography columns market. According to the India Brand Equity Foundation, the Indian pharmaceutical market is expected to grow at a CAGR of 22-25% over 2015–20 to reach US$ 100 billion. Such projected growth in the pharmaceutical industry is expected to significantly increase the demand for prepacked chromatography columns used for drug manufacturing and quality testing. Other key trends include technological advancements resulting in development of miniature columns and growing adoption of axial compression technology for improved biomolecule integrity and recovery.
Porter’s Analysis
Threat of new entrants: The prepacked chromatography columns market requires high capital investments and stringent regulatory protocols. This poses moderate threat of new entrants.
Bargaining power of buyers: Buyers have moderate bargaining power due to availability of various product alternatives in the market.
Bargaining power of suppliers: Suppliers have moderate-to-high bargaining power due to the technical expertise required for manufacturing chromatography columns.
Threat of new substitutes: The threat of new substitutes is low as chromatography columns are widely accepted technique for separation sciences with no close substitute available.
Competitive rivalry: The market experiences high competitive rivalry due to presence of various international and regional players.
Key Takeaways
Global Prepacked Chromatography Columns Market Size is expected to witness high growth, exhibiting CAGR of 7.9% over the forecast period 2023 to 2030, due to increasing R&D investments in biopharmaceutical industry.
Regional analysis: North America region currently dominates the prepacked chromatography columns market and is expected to continue its dominance during the forecast period. This is attributed to presence of major players and availability of funding for R&D in the region. Asia Pacific is anticipated to witness fastest growth during the forecast period ascribing to growing concerns for effective separation technologies, increasing healthcare expenditure, and expansion of key players in emerging Asian countries.
Key players operating in the prepacked chromatography columns market are Thermo Fisher Scientific Inc., Cytiva, Sartorius AG, Repligen Corporation, Merck Millipore, VWR International, Llc. (Avantor), Phenomenex Inc., Agilent Technologies, Inc., Knauer Wissenschaftliche Geräte GmbH, Hawach Scientific Co., Ltd., Purolite, BioServUK Ltd., Astrea Bioseparations Ltd., Daisogel USA (Osaka Soda Co., Ltd.), Shimadzu Corporation, Waters Corporation, Showa Denko K.K, Harvard Bioscience, Inc, Tosoh Corporation, Geno Technology Inc., USA., Santai Science, Biotage, ChromaNik Technologies, Inc., Proxcys B.V., GALAK Chromatography Technology Co., Ltd., and Daicel Corporation.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
